Euclidean Capital LLC Alector, Inc. Transaction History
Euclidean Capital LLC
- $304 Million
- Q2 2025
A detailed history of Euclidean Capital LLC transactions in Alector, Inc. stock. As of the latest transaction made, Euclidean Capital LLC holds 1,307,858 shares of ALEC stock, worth $2.62 Million. This represents 0.6% of its overall portfolio holdings.
Number of Shares
1,307,858
Previous 1,307,858
-0.0%
Holding current value
$2.62 Million
Previous $1.61 Million
13.87%
% of portfolio
0.6%
Previous 0.61%
Shares
2 transactions
Others Institutions Holding ALEC
# of Institutions
140Shares Held
54.6MCall Options Held
29.8KPut Options Held
13.4K-
Black Rock Inc. New York, NY9.1MShares$18.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.99MShares$12 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.88MShares$9.75 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA2.17MShares$4.34 Million0.01% of portfolio
-
Eversept Partners, LP New York, NY1.99MShares$3.97 Million0.28% of portfolio
About Alector, Inc.
- Ticker ALEC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 82,563,904
- Market Cap $165M
- Description
- Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...